Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Hematology/Oncology Clinics of North America|December 6, 2005
Prognostic factors for mesotheliomaJeremy P C SteeleInternational Journal of Cancer|August 8, 2007
Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancerDean A Fennell, Jeremy P C Steele, Jonathan Shamash, et al.Cancer|December 6, 2006
Efficacy and safety of first- or second-line irinotecan, cisplatin, and mitomycin in mesotheliomaDean A Fennell, Jeremy P C Steele, Jonathan Shamash, et al.Lung Cancer (Amsterdam, Netherlands)|May 17, 2005
Prognostic factors in mesotheliomaJeremy P C Steele, Astero Klabatsa, Dean A Fennell, et al.Lung Cancer (Amsterdam, Netherlands)|May 20, 2008
The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesotheliomaJustin Stebbing, Thomas Powles, Kirsty McPherson, et al.Lung Cancer (Amsterdam, Netherlands)|January 11, 2005
Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesotheliomaDean A Fennell, Jeremy P C Steele, Jonathan Shamash, et al.Pageof 1